Evaluate the Efficacy, Safety, and Pharmacokinetic Profile and Immunogenicity of Subcutaneous Netakimab in Chinese Adult Patients With Active Ankylosing Spondylitis
Clinical trial NCT07277179 · COMPLETED
Trial details
- NCT number
- NCT07277179
- Sponsor
- SPH-BIOCAD (HK) Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2024-07-05
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.